EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions

Jessica A Wilcox iD, Ugonma N Chukwueke iD, Myung-Ju Ahn, Ayal A Aizer iD, Tejus A Bale iD, Dieta Brandsma iD, Priscilla K Brastianos iD, Susan Chang iD, Mariza Daras iD, Peter Forsyth iD, Livia Garzia iD, Michael Glantz iD und 17 weitere

Neuro-Oncology · 03.10.2024 · 26 (10) · 1781-1804

DOI: 10.1093/neuonc/noae103 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuro-Oncology, online erschienen am 21.06.2024. Verfasst von Jessica A Wilcox und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Brain Tumor Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Meningeal Neoplasms. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIH/NCI Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leptomeningeal metastases (LM) are increasingly becoming recognized as a treatable, yet generally incurable, complication of advanced cancer. As modern cancer therapeutics have prolonged the lives of patients with metastatic cancer, specifically in patients with parenchymal brain metastases, treatment options, and clinical research protocols for patients with LM from solid tumors have similarly evolved to improve survival within specific populations. Recent expansions in clinical investigation, early diagnosis, and drug development have given rise to new unanswered questions. These include leptomeningeal metastasis biology and preferred animal modeling, epidemiology in the modern cancer population, ensuring validation and accessibility of newer leptomeningeal metastasis diagnostics, best clinical practices with multimodality treatment options, clinical trial design and standardization of response assessments, and avenues worthy of further research. An international group of multi-disciplinary experts in the research and management of LM, supported by the Society for Neuro-Oncology and American Society of Clinical Oncology, were assembled to reach a consensus opinion on these pressing topics and provide a roadmap for future directions. Our hope is that these recommendations will accelerate collaboration and progress in the field of LM and serve as a platform for further discussion and patient advocacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningeal NeoplasmsHumansDisease ManagementMedical OncologyMeningeal CarcinomatosisNeoplasmsSocieties, MedicalUnited States

Stichwörter der Autor:innen

consensus guidelineintrathecal therapyleptomeningeal diseaseleptomeningeal metastasesradiation therapysystemic therapy

Autor:innen und Institutionen

  • Department of Neurology, Brain Tumor Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Radiation Oncology, Brigham and Women's Hospital / Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Neuro-Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

ORCID-Profile: Jessica A Wilcox, Ugonma N Chukwueke, Ayal A Aizer, Tejus A Bale, Dieta Brandsma, Priscilla K Brastianos, Susan Chang, Mariza Daras, Peter Forsyth, Livia Garzia, Michael Glantz, Isabella C Glitza Oliva, Priya Kumthekar, Emilie Le Rhun, Seema Nagpal, Elena Pentsova, Eudocia Quant Lee, Jan Remsik, Roberta Rudà, Inna Smalley, Michael Weller, Jeffrey Wefel, Jonathan T Yang, Patrick Y Wen, Adrienne A Boire

Förderung

  • NCI NIH HHS
  • NIH/NCI Cancer Center

Zitieren

APA

Wilcox, J. A., Chukwueke, U. N., Ahn, M. J., Aizer, A. A., Bale, T. A., Brandsma, D., Brastianos, P. K., Chang, S., Daras, M., Forsyth, P., Garzia, L., Glantz, M., Oliva, I. C. G., Kumthekar, P., Le Rhun, E., Nagpal, S., O'Brien, B., Pentsova, E., Lee, E. Q., …, & Boire, A. A. (2024). Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions. Neuro-Oncology, 26(10), 1781-1804. https://doi.org/10.1093/neuonc/noae103

Vancouver

Wilcox JA, Chukwueke UN, Ahn MJ, Aizer AA, Bale TA, Brandsma D, et al. Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions. Neuro-Oncology. 2024;26(10):1781-1804. doi:10.1093/neuonc/noae103

BibTeX
@article{Wilcox2024,
  author = {Wilcox, Jessica A and Chukwueke, Ugonma N and Ahn, Myung-Ju and Aizer, Ayal A and Bale, Tejus A and Brandsma, Dieta and Brastianos, Priscilla K and Chang, Susan and Daras, Mariza and Forsyth, Peter and Garzia, Livia and Glantz, Michael and Oliva, Isabella C Glitza and Kumthekar, Priya and Le Rhun, Emilie and Nagpal, Seema and O'Brien, Barbara and Pentsova, Elena and Lee, Eudocia Quant and Remsik, Jan and Rudà, Roberta and Smalley, Inna and Taylor, Michael D and Weller, Michael and Wefel, Jeffrey and Yang, Jonathan T and Young, Robert J and Wen, Patrick Y and Boire, Adrienne A},
  title = {Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions},
  journal = {Neuro-Oncology},
  year = {2024},
  volume = {26},
  number = {10},
  pages = {1781--1804},
  doi = {10.1093/neuonc/noae103}
}
Kostenlos starten →